Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability
Yıl: 2022 Cilt: 39 Sayı: 1 Sayfa Aralığı: 72 - 74 Metin Dili: İngilizce DOI: 10.4274/tjh.galenos.2021.2021.0598 İndeks Tarihi: 21-06-2022
Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability
Öz:Konjenital Hipotransferinemide İkinci Dekatta Plazma ve Demir Tedavisi: Hematolojik Stabiliteyi Korumak için Dinamik Yaklaşım
Öz: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. Goldwurm S, Casati C, Venturi N, Strada S, Santambrogio P, Indraccolo S, Arosio P, Cazzola M, Piperno A, Masera G, Biondi A. Biochemical and genetic defects underlying human congenital hypotransferrinemia. Hematol J 2000;1:390-398.
- 2. Beutler E, Gelbart T, Lee P, Trevino R, Fernandez MA, Fairbanks VF. Molecular characterization of a case of atransferrinemia. Blood 2000;96:4071-4074.
- 3. Fairbanks VF, Brandhagen DJ. Disorders of iron storage and transport. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U (eds). Williams Hematology. New York, McGraw-Hill, 2001.
- 4. Aslan D. Addition of oral iron to plasma transfusion in human congenital hypotransferrinemia: a 10-year observational follow-up with the effects on hematological parameters and growth. Pediatr Blood Cancer 2018;65:e26789.
- 5. Li H, Ginzburg YZ. Crosstalk between iron metabolism and erythropoiesis. Adv Hematol 2010;2010:605435.
- 6. Trombini P, Coliva T, Nemeth E, Mariani R, Ganz T, Biondi A, Piperno A. Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007;92:1407-1410.
- 7. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91:727-732.
- 8. Bartnikas TB, Andrews NC, Fleming MD. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 2011;117:630-637. 9. Coffey R, Ganz T. Erythroferrone: An erythroid regulator of hepcidin and iron metabolism. Hemasphere 2018;2:e35.
- 10. Boshuizen M, van der Ploeg K, von Bonsdorff L, Biemond BJ, Zeerleder SS, van Bruggen R, Juffermans NP. Therapeutic use of transferrin to modulate anemia and conditions of iron toxicity. Blood Rev 2017;31:400-405.
| APA | Aslan d (2022). Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. , 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| Chicago | Aslan deniz Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. (2022): 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| MLA | Aslan deniz Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. , 2022, ss.72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| AMA | Aslan d Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. . 2022; 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| Vancouver | Aslan d Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. . 2022; 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| IEEE | Aslan d "Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability." , ss.72 - 74, 2022. 10.4274/tjh.galenos.2021.2021.0598 |
| ISNAD | Aslan, deniz. "Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability". (2022), 72-74. https://doi.org/10.4274/tjh.galenos.2021.2021.0598 |
| APA | Aslan d (2022). Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. Turkish Journal of Hematology, 39(1), 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| Chicago | Aslan deniz Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. Turkish Journal of Hematology 39, no.1 (2022): 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| MLA | Aslan deniz Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. Turkish Journal of Hematology, vol.39, no.1, 2022, ss.72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| AMA | Aslan d Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. Turkish Journal of Hematology. 2022; 39(1): 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| Vancouver | Aslan d Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability. Turkish Journal of Hematology. 2022; 39(1): 72 - 74. 10.4274/tjh.galenos.2021.2021.0598 |
| IEEE | Aslan d "Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability." Turkish Journal of Hematology, 39, ss.72 - 74, 2022. 10.4274/tjh.galenos.2021.2021.0598 |
| ISNAD | Aslan, deniz. "Fresh Frozen Plasma Plus Iron Therapy in Congenital Hypotransferrinemia in the Second Decade: A Dynamic Approach to Maintaining Hematological Stability". Turkish Journal of Hematology 39/1 (2022), 72-74. https://doi.org/10.4274/tjh.galenos.2021.2021.0598 |
